The Independent Voice of
European Private Equity

Advanced Search

Riverside invests in HealthTech BioActives

olly.jackson@realdealsmedia.com 13 December 2019

The Riverside Company has invested in HealthTech BioActives (HTBA), a Spanish manufacturer of active pharmaceutical ingredients for the pharma, nutraceutical and cosmetic industries, from its Riverside Europe Fund VI (REF...

Related Articles

Profile: Fondo Italiano d’Investimento celebrates raise of €1.2bn despite headwinds

08/05/24

Naxicap Partners acquires majority stake in spare parts distributor ITAL Express

08/05/24

Patrimonium and Wille Finance invest in EM

08/05/24

Montagu-backed HTL Biotechnology carves out Modern Meadow biomedical division

08/05/24

Squire Patton Boggs hires leveraged finance partner

08/05/24

Livonia Partners invests in Baltic tech firm Telema

08/05/24